GOVX GeoVax Labs Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: GOVX

Price (delayed)

$1.59

Market cap

$3.45M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$14.29

Enterprise value

-$3M

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) based vaccine platform. On ...

Highlights
The quick ratio has plunged by 69% YoY but it has grown by 2.2% from the previous quarter
GeoVax Labs's revenue has shrunk by 100% YoY
The company's gross profit has shrunk by 100% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.geovax.com
Peers: ADXS ABBV

Key stats

What are the main financial stats of GOVX
Market
Shares outstanding
2.17M
Market cap
$3.45M
Enterprise value
-$3M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.49
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$25.97M
EBITDA
-$25.89M
Free cash flow
-$25.22M
Per share
EPS
-$14.29
Free cash flow per share
-$13.88
Book value per share
$3.24
Revenue per share
$0
TBVPS
$5.11
Balance sheet
Total assets
$9.28M
Total liabilities
$3.52M
Debt
$0
Equity
$5.76M
Working capital
$4.37M
Liquidity
Debt to equity
0
Current ratio
2.24
Quick ratio
1.83
Net debt/EBITDA
0.25
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-140.1%
Return on equity
-189.2%
Return on invested capital
N/A
Return on capital employed
-450.6%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GOVX stock price

How has the GeoVax Labs stock price performed over time
Intraday
8.9%
1 week
8.9%
1 month
-16.32%
1 year
164.56%
YTD
340.44%
QTD
-20.5%

Financial performance

How have GeoVax Labs's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$26.74M
Net income
-$25.97M
Gross margin
N/A
Net margin
N/A
GeoVax Labs's revenue has shrunk by 100% YoY
The company's gross profit has shrunk by 100% YoY
The operating income has plunged by 91% YoY and by 9% from the previous quarter
GeoVax Labs's net income has plunged by 85% YoY and by 9% from the previous quarter

Growth

What is GeoVax Labs's growth rate over time

Valuation

What is GeoVax Labs stock price valuation
P/E
N/A
P/B
0.49
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 15% year-on-year and by 8% since the previous quarter
The equity has dropped by 78% year-on-year and by 37% since the previous quarter
The P/B is 59% less than the last 4 quarters average of 1.2
GeoVax Labs's revenue has shrunk by 100% YoY

Efficiency

How efficient is GeoVax Labs business performance
The ROA has dropped by 200% year-on-year and by 42% since the previous quarter
The return on equity has dropped by 51% since the previous quarter

Dividends

What is GOVX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GOVX.

Financial health

How did GeoVax Labs financials performed over time
GOVX's total assets is 164% more than its total liabilities
GOVX's total assets has plunged by 70% YoY and by 43% from the previous quarter
The quick ratio has plunged by 69% YoY but it has grown by 2.2% from the previous quarter
The debt is 100% smaller than the equity
The equity has dropped by 78% year-on-year and by 37% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.